PCYC Financial Facts
Net loss: 4.15MTotal revenues: 205.77M
See Full Income Statement
See Full Balance Sheet
Pharmacyclics, Inc. (PCYC) Earnings
|
Expand Research on PCYC
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +97.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +8.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/15  |
Q115 | $0.43 | $0.11 | +$0.32 | $206M | $226.27M | N/A |  | | Details | |
| 2/18/15 |
 |
Q414 | $0.96 | $0.76 | +$0.20 | $290M | $267.5M | N/A | | | Details |
| 11/4/14 |
|
Q314 | $0.69 | $0.37 | +$0.32 | $307M | $201.5M | N/A | | | Details |
| 7/31/14 |
|
Q214 | -$0.26 | -$0.23 | -$0.03 | $113M | $95.88M | N/A | | | Details |
| 5/2/14 |
|
Q114 | $0.40 | $0.17 | +$0.23 | $119.4M | $105.38M | N/A | | | Details |
| 2/20/14 | Q413 | $0.95 | $0.67 | +$0.28 | $123.6M | $85.69M | N/A | | | Details | |
| 7/31/13 |
|
Q313 | $0.26 | -$0.07 | +$0.33 | $54.7M | $52M | = | | | Details |
| 2/14/13 |
|
Q213 | $0.62 | $0.29 | +$0.33 | $57.96M | $45.74M | = | | | Details |
